FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Right Issue Status: Closed [7th Aug 2023 to 22nd Aug 2023]
Brooks Laboratories Limited offers Right Issue size of 1,543,926 equity shares worth of Rs 11.58 Cr. The subscription for this Rights Issue is opening from 7 Aug 2023 to 14 Aug 2023. The company issues 1 Rights equity shares for every fully paid-up 16 equity shares held on the record date of 28 July 2023. The face value of a share is Rs.10 per share and the right issue price is fixed at Rs. 75 per share.
Stay updated with us to know more about the Brooks Laboratories Limited Right Issue Details 2023 including issue size, right issue entitlement, terms of payment, sand more.
The company intends to utilize the net proceeds from the issue towards the funding of the following objects:
Brooks Laboratories Issue Details | Values |
---|---|
Category | RightIssue |
Right Issue Issue Size (Shares) | 0.15 Cr Shares |
Right Issue Issue Size (Amount) | ₹11.58 Cr |
Face Value | ₹10 Per Equity Share |
Right Issue - Issue Price | ₹75 per share |
Right Issue Record Date | 28th Jul 2023 |
Right Issue Entitlement | 1 Rights Equity Share(s) for every 16 fully paid-up Equity Shares held on Record Date |
Right Issue Terms of payment | Full amount of Rs. 75 for rights equity shares has to be paid on application. |
Listing At | BSE, NSE |
BSE Code | 533543 |
NSE Code | BROOKS |
In this section we have covered all important dates related to Brooks Laboratories Right Issue. Dates are updated as they are announced. The most noted dates are Right Issue start date and Right Issue end date, which one should use to participate in Right Issue.
Right Issue Activity | Date |
---|---|
Right Issue Issue Open Date | 7th Aug 2023 |
Right Issue Issue Close Date | 22nd Aug 2023 |
Basis of Allotment Finalisation Date* | 29th Aug 2023 |
Refunds Initiation* | 17th Aug 2023 |
Credit of Shares to Demat Account* | 30th Aug 2023 |
Right Issue Listing Date* | 1st Sep 2023 |
* - Tentative Dates
Zerodha Trade@20
Brooks Laboratories Limited was established in January 2002. The company is engaged in the manufacture and marketing of pharmaceuticals both domestically and internationally. Brooks Laboratories is a pharmaceutical contract research and manufacturing company that offers a wide range of intensive care products for parents, such as beta-lactam, general dry powder injectables, ampoules and liquid vials, dry syrups and tablets, etc. The product range includes:
The company's products face strong competition from products marketed or under development by competitors in all therapeutic areas. They compete with local companies, multinational corporations and companies from the rest of the world. The company faces significant competition from other large and small pharmaceutical companies. They compete based on a number of factors, including execution, depth of product and service offerings, innovation, reputation, and price.
In a short period of time, Brooks Laboratories has developed its own marketing and training department. The training department trains all sales staff prior to their introduction, while the marketing department oversees the proper formulation and execution of marketing strategies. The Group has its own strong supply chain with more than 300 distributors. This ensures smooth transportation of goods and quick availability.
Past performance and financial results of Brooks Laboratories .
Period Ended | 31 Mar 2022 | 31 Mar 2023 |
Assets | 195.91 | 109.60 |
Revenue | 91.99 | 63.41 |
Profit After Tax | -18.31 | -31.05 |
Net Worth | ||
Reserves and Surplus | ||
Total Borrowing |
The table below is live update of Right Issue bidding details from NSE and BSE.
Brooks Laboratories Right Issue Offer Document (Letter of Offer) >>Document
Brooks Laboratories Right Issue Offer Document (Letter of Offer) >>Brooks Laboratories Right Issue Red Herring Prospectus is not yet available.
Brooks Laboratories Right Issue Online Application (Registrar & Transfer Agent) >>Online Application
Brooks Laboratories Right Issue Online Application (Registrar & Transfer Agent) >>Brooks Laboratories Right Issue RTA information is not yet available.
Last Updated on 2023-08-25T05:32:51+00:00